Israel's Redhill Biopharma gets green light for experimental ...

health

Israeli biopharmaceutical firm RedHill Biopharma Ltd. on Monday said it had administered its experimental drug Opaganib to a COVID-19 patient in Israel for the first time, and received a green light from Italian officials to use the drug to treat the disease in Italy. The drug has the potential to treat symptoms of COVID-19, the disease caused by the novel coronavirus, but is not a vaccine or meant to build immunity or prevent infections in any way. if(typeof rgb_remove_toi_dfp_banner != "function" || !rgb_remove_toi_dfp_banner("#div-gpt-ad-336x280_Middle_1")){ googletag.cmd.push(function() { googletag.display("div-gpt-ad-336x280_Middle_1"); }); }; The Israeli patient, who is suffering respiratory symptoms at an unnamed hospital in Israel, took the drug under compassionate use guidelines with approval from ...

timesofisrael.com     Apr 07, 2020